Cadwalader Takes Corporate Inversions to Another Level

Cadwalader, Wickersham & Taft may have found a way to help more U.S. companies use corporate inversions to lower their tax bills. Salix Pharmaceuticals has retained the firm, as well as Covington & Burling and leading Irish shop A&L Goodbody, for its $2.7 billion acquisition of patents to gastrointestinal drugs owned by an Irish unit of Italy's Cosmo Pharmaceuticals.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.